| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |